In a story about BioCryst Pharmaceutical Inc.'s quarterly results, The Associated Press reported erroneously, in a report generated by Automated Insights using data from Zacks Investment Research, that the company is based in Birmingham, Alabama. It's based in Durham, North Carolina.
A corrected version of the story is below:
BioCryst reports 4Q loss
BioCryst Pharmaceuticals posts 4Q revenue of $5.4 million, result beats expectations
DURHAM, N.C. (AP) — BioCryst Pharmaceuticals Inc. (BCRX) on Wednesday reported a loss of $11.7 million in its fourth quarter.
The Durham, North Carolina-based company said it had a loss of 16 cents per share.
The drugmaker posted revenue of $5.4 million in the period, topping Street forecasts. Analysts expected $3.4 million, according to Zacks.
For the year, the company reported that its loss widened to $45.2 million, or 68 cents per share. Revenue was reported as $13.6 million.
BioCryst shares have declined 17 percent since the beginning of the year. The stock has risen 4 percent in the last 12 months.
Elements of this story were generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BCRX at http://www.zacks.com/ap/BCRX
Keywords: BioCryst Pharmaceuticals, Earnings Report